In a consecutive series of 41 hirsute women clinically classified as benign androgen excess, only 34 %were found to have elevated plasma 'total' testosterone (T), 22 %having subnormal sex hormone binding globulin (SHBG). When expressed as the ratio T jSHBG ('free androgen index'), 85 % of the patients had values above the normal range. It is concluded that this index is more
reliable than total testosterone in assessing androgen status in female patients.
Total testosterone (nmol/l) x 100 SHBG (nmol DHTII) 24·9 years, range 20-35). Neither group of subjects was receiving the contraceptive pill or other form of medication known to interfere with androgen metabolism. None of the hirsute patients showed evidence of virilism and all were provisionally diagnosed as having 'benign androgen excess'.
Plasma total testosterone was measured by the radioimmunoassay of Collins et a[6 using an antiserum donated by Mr Mike Mansfield (Chelsea Hospital for Women). Plasma SHBG was assayed by the two-tier column method of Iqbal and Johnson"; results are expressed in terms of the uptake of 51X-dihydrotestosterone (DHT). Free androgen index (FAl) was calculated as the ratio:
Results
Statistical analysis of results employed Student's t test. Results of grouped data are expressed as the mean ± 1 SEM.
Patients and methods
The results are presented in the Figure. Normal ranges (mean ± 2 SD), calculated from the results obtained in the control group, were as follows: Testosterone 0·8-3·2 nmol/l: SHBG 25-121 nmol DHT/I: FAIl·3-4· 5. Of the 41 hirsute women, only 14 (34 %) had a plasma testosterone which fell outside the normal range, although the group mean Forty-one consecutive premenopausal women (mean (2·5 ± 0·18 nmol/l) was significantly higher than age 27·4 years, range 19-50) referred to the Depart-that of the controls (2·0 ± 0·09 nmol/l)(p<O·01).
ment of Endocrinology for evaluation of hirsutism
The mean SHBG in the hirsute subjects (34 ± 1·9 were compared with 32 female controls (mean age nmol DHT/I) was significantly below that of the 262
The diagnosis of androgen excess is frequently considered in patients with hirsutism or acne as well as in those with menstrual irregularities and infertility. Androgen status in these patients is often evaluated by measuring plasma testosterone, although it has been shown that this steroid is elevated in less than 50 % of cases of 'benign androgen excess' .1 This is because the majority of endocrine laboratories measure 'total' testosterone (T), of which 97-99% is bound to plasma proteins.s much of it to sex hormone binding globulin (SHBG).
Since biological activity is associated with the unbound fraction, a more appropriate investigation would be the measurement of plasma free testosterone, but this is technically demanding, and assays are not widely available. Salivary testosterone is a promising alternative.s ! but major differences between the reported normal ranges suggest fundamental methodology problems which may delay its introduction into the routine laboratory. The ratio T ISHBG ('free androgen index') has been suggested as a better discriminator than total testosterone in the evaluation of hirsute patients.' I> This has the advantage of being based on two well-established assays, both of which can be monitored by external quality assessment schemes.
This report describes the use of the free androgen index in the investigation of women with benign androgen excess. controls (73 ± 4·3 nmol DHT/l) (p<O',OOI); nine patients (22 %) had subnormal levels, including seven whose plasma testosterone was normal. When results were expressed as the free androgen index there was even better discrimination between the patients (mean FAT 8·3 ± 0·8) and controls (mean FAT 2·9 ± 0·15)(p <0·001); 35 (85 %) of the hirsute women had a FAT which fell above the normal range.
In addition, the single control subject with a raised testosterone (3·5 nmol/l) had a normal FAT (3· 7).
Discussion
Although possibly suitable for detecting the gross changes that can occur in androgen-secreting tumours of the ovary or adrenal, measurement of 'total' testosterone alone clearly does not invariably detect the more subtle changes that occur in benign 263 androgen excess. This is probably because even small increases in testosterone can reduce its own binding protein, SHBG, thereby causing relatively large increases in biologically active free steroid. The present study confirms a previous report by Mathur et all and underlines the discriminatory value of a SHBG measurement when used with testosterone to calculate the free androgen index. As a biochemical marker, the index offers a more reliable reflection of androgen status than total testosterone alone and should help to clarify the androgen component in hirsutism, acne, menstrual disturbances, and infertility.
